Raphael Ognar | President & Chief Executive Officer, Co-Founder
NKILT Therapeutics Inc.

Pharma/Biotech senior executive with over 26 years of commercial, drug development, product lifecycle and strategy expertise. His multiple achievements through global and country leading roles (Novartis Oncoloy, Celgene, BMS),  and his proven leadership skills came from an extensive 21-year experience in Oncology/Hematology. For the last decade, he successfully increased his focus on Immuno-Oncology and Cell Therapy technologies, leading to the creation of NKILT Therapeutics, Inc., in 2021. After his time in Corporate Pharma/Biotech, and prior to founding NKILT Therapeutics, Inc., he created his executive consulting company, ANIM8 LLC,  to deliver strategy and operations support to early-stage biotech and RWE/DHS companies. Raphaël owns a Masters and a D.E.A. of Physiology and Neurosciences from University of Bordeaux I&II, and an MBA in Strategic Marketing and Enterprise Management from I.A.E of Tours University. Besides fighting cancer, his passions are vintage wines, playing music in his family band, playing and chilling with his rescued pitbulls, pushing himself rock climbing and traveling the world with family and friends.